Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company CellProthera S.A.S.
DescriptionAutologous CD34+ stem cells
Molecular Target CD34
Mechanism of Action 
Therapeutic ModalityCell therapy: Stem cell
Latest Stage of DevelopmentPreclinical
Standard IndicationMyocardial infarction (MI)
Indication DetailsRepair myocardial tissue after acute myocardial infarction (AMI)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today